RIGL
USDRigel Pharmaceuticals Inc. Common Stock
$28.380-1.710 (-5.683%)
Precio en Tiempo Real
Healthcare
Biotecnología
Estados Unidos
Gráfico de Precios
Loading Chart...
Métricas Clave
Métricas de Mercado
Apertura
$30.090
Máximo
$30.795
Mínimo
$28.080
Volumen
0.31M
Fundamentos de la Empresa
Capitalización de Mercado
509.1M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.71M
Bolsa
NMS
Moneda
USD
Rango de 52 Semanas
Mínimo $13.91Actual $28.380Máximo $43.72
Noticias Relacionadas
PR Newswire
Rigel Announces One Oral and Four Poster Presentations at the 67th American Society of Hematology Annual Meeting and Exposition
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced...
Ver más
CNBC
This biotech stock has jumped nearly 50% in 3 months. Its CEO says business is 'growing substantially'
Rigel Pharmaceuticals has landed on CNBC's list of top performing stocks of companies located in San Francisco.
Ver más
PR Newswire
Rigel Announces Conference Call and Webcast to Report Third Quarter 2025 Financial Results and Business Update
Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will report its third quarter 2025 financial results after market close on...
Ver más
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.